The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Pharmaceutical ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Despite significant advances in addiction science, a persistent and critical challenge remains: the vast chasm between the ...

The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue ...

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...